Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pulmonx CorpLUNG · Entity 2359 | Chief Science & Techn. Officer | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pulmonx Corp
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 316,994 |
Ending reported balance
After 2026-09-01 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-01 · Sale · Disposed 2,643 · Balance 328,596 F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023. Row 2 · 2026-09-01 · Sale · Disposed 2,121 · Balance 326,475 F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Row 3 · 2026-09-01 · Sale · Disposed 3,618 · Balance 322,857 F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Row 4 · 2026-09-01 · Sale · Disposed 5,863 · Balance 316,994 F4: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.
F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.
F4: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 3, 2026 22:21 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 5,863 | $2.26 | $13,250.38 |
DisclosureSEC source: 0002098678-26-000004 · form4-09032026_100954.xml · nonDerivative · entry 4 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science & Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,994 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:21 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,618 | $2.26 | $8,176.68 |
DisclosureSEC source: 0002098678-26-000004 · form4-09032026_100954.xml · nonDerivative · entry 3 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science & Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,857 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:21 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,121 | $2.26 | $4,793.46 |
DisclosureSEC source: 0002098678-26-000004 · form4-09032026_100954.xml · nonDerivative · entry 2 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science & Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,475 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:21 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,643 | $2.26 | $5,973.18 |
DisclosureSEC source: 0002098678-26-000004 · form4-09032026_100954.xml · nonDerivative · entry 1 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science & Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,596 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 5,969 | $1.54 | $9,192.26 |
DisclosureSEC source: 0002098678-26-000002 · form4-06032026_080611.xml · nonDerivative · entry 4 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science &Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,239 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 2, 2026. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,684 | $1.54 | $5,673.36 |
DisclosureSEC source: 0002098678-26-000002 · form4-06032026_080611.xml · nonDerivative · entry 3 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science &Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 337,208 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,153 | $1.54 | $3,315.62 |
DisclosureSEC source: 0002098678-26-000002 · form4-06032026_080611.xml · nonDerivative · entry 2 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science &Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,892 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,691 | $1.54 | $4,144.14 |
DisclosureSEC source: 0002098678-26-000002 · form4-06032026_080611.xml · nonDerivative · entry 1 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science &Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,045 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:07 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 175,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002098678-26-000001 · form4-03052026_120355.xml · nonDerivative · entry 5 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science &Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,736 F5 · shares: Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 2, 2026. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:07 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 4,198 | $1.43 | $6,003.14 |
DisclosureSEC source: 0002098678-26-000001 · form4-03052026_120355.xml · nonDerivative · entry 4 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science &Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,736 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:07 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 2,461 | $1.43 | $3,519.23 |
DisclosureSEC source: 0002098678-26-000001 · form4-03052026_120355.xml · nonDerivative · entry 3 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science &Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,934 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:07 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 3,068 | $1.43 | $4,387.24 |
DisclosureSEC source: 0002098678-26-000001 · form4-03052026_120355.xml · nonDerivative · entry 2 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science &Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,395 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:07 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 756 | $1.43 | $1,081.08 |
DisclosureSEC source: 0002098678-26-000001 · form4-03052026_120355.xml · nonDerivative · entry 1 Radhakrishnan Srikanth · CIK 0002098678 · Chief Science &Techn. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,463 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.